Skip to content

Effect of Parnfuti in prevention of stone formation and reduction of stone size in patients of renal stone disease.

Efficacy and Safety of Bryophyllum Pinnatum (Lam.) in Patients of Renal Stone: A Prospective, Parallel group, Randomized, Open Labelled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007425
Enrollment
100
Registered
2016-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Renal stone size between 8 mm and 11 mm

Interventions

Intervention1: Bryophyllum Pinnatum 500mg 24 hourly add on to Hydrochlorthiazide 12.5mg tablet 24 hourly.: The treatment will be given for total of three months Control Intervention1: tablet Hydrochlo

Sponsors

Department of Pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients of both the genders aged > 18 Years of age. •Renal stone >8 mm and •Total leucocyte count and Serum creatinine level within normal range. •Ability to tolerate oral fluids and Analgesic drugs. •Patientâ??s willingness for follow up. •Patient not on contraceptives or calcium therapy. •Patient not involved in any other clinical trial in last 30 days. •Patient not having Dementia or other cognitive disorders prohibiting informed consent.

Exclusion criteria

Exclusion criteria: •Children and elderly patient. •Pregnancy or planning for pregnancy. •Lactating mother. •History of any substance abuse. •Active urinary tract infection •Obstructive Uropathy, Benign prostatic hyperplasia or hydronephrosis. •Any malignancy. •People leaving with HIV AIDS (PLHA). •Hepatitis-B, Hepatitis-C. •Person with single Kidney. •Previous renal surgery. •Cardiac diseases, Hypertension or Patient on diuretics. •Metabolic disorders (Hyper thyroidism, Hyper para thyroidism) •Known case of Gout.

Design outcomes

Primary

MeasureTime frame
Renal function test X-ray KUB USG KUB Urine testsTimepoint: 1 month, 2 month, 3 month. Urine tests

Secondary

MeasureTime frame
need of rescue treatment, Safety dataTimepoint: Any time during study, and at the time of follow up at 1 month, 2 month, 3 month.

Countries

India

Contacts

Public ContactDr C B Tripathi

Government Medical College, Bhavnagar

cbrtripathi@yahoo.co.in09825951678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026